Yarbrough Capital, LLC Cellebrite Di Ltd. Transaction History
Yarbrough Capital, LLC
- $2.75 Billion
- Q2 2025
A detailed history of Yarbrough Capital, LLC transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 21,044 shares of CLBT stock, worth $305,979. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,044Holding current value
$305,979% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding CLBT
# of Institutions
208Shares Held
90.8MCall Options Held
177KPut Options Held
84.2K-
True Wind Capital Management, L.P.13.9MShares$202 Million92.82% of portfolio
-
Morgan Stanley New York, NY3.96MShares$57.6 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA3.92MShares$57 Million0.22% of portfolio
-
Voss Capital, LLC Houston, TX3.84MShares$55.9 Million6.97% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L33.34MShares$48.6 Million0.67% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $2.76B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...